ZA926967B - 4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phynyl)-5-methyl-3-H-1,2,4-triazol-3-one derivatives - Google Patents

4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phynyl)-5-methyl-3-H-1,2,4-triazol-3-one derivatives

Info

Publication number
ZA926967B
ZA926967B ZA926967A ZA926967A ZA926967B ZA 926967 B ZA926967 B ZA 926967B ZA 926967 A ZA926967 A ZA 926967A ZA 926967 A ZA926967 A ZA 926967A ZA 926967 B ZA926967 B ZA 926967B
Authority
ZA
South Africa
Prior art keywords
phynyl
triazol
piperazinyl
hydroxyphenyl
derivatives
Prior art date
Application number
ZA926967A
Other languages
English (en)
Inventor
Jan Heeres
Joseph Hector Mostmans
Johan Rene Mark Beetens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ZA926967B publication Critical patent/ZA926967B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA926967A 1991-09-13 1992-09-11 4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phynyl)-5-methyl-3-H-1,2,4-triazol-3-one derivatives ZA926967B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91202351 1991-09-13

Publications (1)

Publication Number Publication Date
ZA926967B true ZA926967B (en) 1994-03-11

Family

ID=8207873

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA926967A ZA926967B (en) 1991-09-13 1992-09-11 4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phynyl)-5-methyl-3-H-1,2,4-triazol-3-one derivatives

Country Status (15)

Country Link
US (1) US5254553A (hu)
EP (1) EP0532091A1 (hu)
JP (1) JPH05194436A (hu)
KR (1) KR930006009A (hu)
CN (1) CN1071420A (hu)
AU (1) AU652069B2 (hu)
BG (1) BG96815A (hu)
CA (1) CA2076257A1 (hu)
FI (1) FI923723A (hu)
HU (1) HUT62884A (hu)
IL (1) IL102863A (hu)
MX (1) MX9205186A (hu)
NO (1) NO923532L (hu)
NZ (1) NZ244297A (hu)
ZA (1) ZA926967B (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW279864B (hu) * 1993-02-19 1996-07-01 Janssen Pharmaceutica Nv
ATE207910T1 (de) * 1994-04-06 2001-11-15 Janssen Pharmaceutica Nv Anti-helicobacter ester- oder carbamatderivate von azolonen
US5607932A (en) * 1994-07-12 1997-03-04 Janssen Pharmaceutica N.V. Heterocyclic derivatives of azolones
US5571811A (en) * 1994-07-12 1996-11-05 Janssen Pharmaceutica N.V. Sulfonamide derivatives of azolones
US6001866A (en) * 1995-10-05 1999-12-14 Warner-Lambert Company Method for treating and preventing inflammation and atherosclerosis
NZ624963A (en) 2009-04-29 2016-07-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
DK2623499T3 (da) * 2010-10-01 2015-06-08 Taisho Pharmaceutical Co Ltd 1,2,4-triazolonderivat
KR101715448B1 (ko) * 2014-07-16 2017-03-20 주식회사 큐리언트 염증성 질환 치료용 화합물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1292472C (en) * 1985-12-03 1991-11-26 Alfonsus Guilielmus Knaeps Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles
US4791111A (en) * 1985-12-23 1988-12-13 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols

Also Published As

Publication number Publication date
EP0532091A1 (en) 1993-03-17
AU652069B2 (en) 1994-08-11
FI923723A (fi) 1993-03-14
JPH05194436A (ja) 1993-08-03
HU9202914D0 (en) 1992-11-30
NO923532L (no) 1993-03-15
MX9205186A (es) 1993-03-01
US5254553A (en) 1993-10-19
NZ244297A (en) 1994-03-25
CA2076257A1 (en) 1993-03-14
AU2281992A (en) 1993-03-18
NO923532D0 (no) 1992-09-11
CN1071420A (zh) 1993-04-28
BG96815A (bg) 1993-12-24
HUT62884A (en) 1993-06-28
KR930006009A (ko) 1993-04-20
FI923723A0 (fi) 1992-08-19
IL102863A (en) 1996-05-14
IL102863A0 (en) 1993-01-31

Similar Documents

Publication Publication Date Title
HU9302460D0 (en) 5/20/4-(1,2-benzisothiazole-3-yl)-1-pierazinyl/ethyl/-6-chlorine-1,3-dihydro-2h-indole-2-one-hydrogen-chloride-mononhydrate
GR3015430T3 (en) 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide sulphate (2:1).
GR3032723T3 (en) 10-desacetoxytaxol derivatives.
AU2378988A (en) 4-(N-3-pyridylmethyl)-amino-1,2,4-triazinones
HU9202848D0 (en) 1,2-dihydro-2-oxopyridine
EP0569493A4 (en) Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines
GB9220658D0 (en) Substituted 2,6-diaminotoluenes
ZA929934B (en) Heterocyclic derivatives.
ZA928742B (en) Heterocyclic derivatives.
ZA926967B (en) 4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phynyl)-5-methyl-3-H-1,2,4-triazol-3-one derivatives
ZA917516B (en) Substituted 5-alkoxy-1,2,4-triazol-3-(thi)ones
ZA924066B (en) Benzo-1,2,3-thiadiazole derivatives
AU7760987A (en) 5-(1-piperazinyl)-1,2,4 triazole derivatives
HU908313D0 (en) New 15-nitro-2betha, 3betha-dihydro- and 15-nitro-2betha, 3 betha,6,7-tetrahydro-tabersonine derivatives
ZA925691B (en) 2-(Imidazol-1-yl)-2-benzylethylidene-aminoxyalkonoic acid derivatives.
NZ300041A (en) 2-(2,3,5,6-tetrafluoropyridin-4-yl)-1,2,5-thiazolidin-3-one 1,1-dioxide derivatives
OA09328A (en) "Heterocyclic compounds".
HU9202296D0 (en) 3,4-dehydro-piperidine derivatives
ZA926417B (en) New heterocyclic derivatives.
EP0447345A3 (en) New azaspyro (4.5) decane-7,9-dione derivatives
AU1680092A (en) 2-amido-1,2,4-triazolinone derivatives
EP0502307A3 (en) Substituted 4,5-diamino-1,2,4-triazol-3-(thi)ones
HU913337D0 (en) Well -bore, "farmaer"
ZA927963B (en) Oxazolidone derivatives.
IE901844L (en) 1,2,4-triazole derivatives